Recent Quotes (30 days)

You have no recent quotes
chg | %

Mitsubishi Tanabe Pharma Corporation  

(Public, TYO:4508)   Watch this stock  
Find more results for 4508
1,409.00
+17.00 (1.22%)
Apr 18 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 1,391.00 - 1,409.00
52 week 1,210.00 - 1,556.00
Open 1,398.00
Vol / Avg. 750,400.00/1.09M
Mkt cap 790.44B
P/E 15.65
Div/yield 20.00/2.84
EPS 90.01
Shares 560.99M
Beta     -
Inst. own     -
May 8, 2014
Full Year 2014 Mitsubishi Tanabe Pharma Corp Earnings Release Add to calendar
Mar 3, 2014
Mitsubishi Tanabe Pharma Corp at Daiwa Investment Conference Tokyo
Feb 24, 2014
Mitsubishi Tanabe Pharma Corp at CLSA Japan Forum
Feb 3, 2014
Q3 2014 Mitsubishi Tanabe Pharma Corp Earnings Conference Call and Webcast - Webcast
Feb 3, 2014
Q3 2014 Mitsubishi Tanabe Pharma Corp Earnings Conference Call and Webcast (Japanese) - Webcast
Feb 3, 2014
Q3 2014 Mitsubishi Tanabe Pharma Corp Earnings Release
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 12.73% 10.01%
Operating margin 19.96% 15.03%
EBITD margin - 20.92%
Return on average assets 6.87% 4.97%
Return on average equity 7.99% 5.72%
Employees 8,835 -
CDP Score - -

Address

Yodoyabashi Square 2-6-18, Kitahama, Chuo-ku
OSAKA-SHI, OSK 541-8505
Japan
+81-6-62055085 (Phone)
+81-6-62055262 (Fax)

Website links

Description

Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Medical Supplies segment is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Others segment is engaged in the manufacture, purchase and sale of chemical products, as well as the management of real estate. On September 18, 2013, together with Philip Morris Investments B.V., the Company acquired all shares of Canada-based pharmaceutical company Medicago Inc., and then made it become a 60%-owned consolidated subsidiary. On April 1, 2014, the Company transferred all shares of a Tochigi-based wholly owned subsidiary to CMIC Holdings Co., Ltd.

Officers and directors

Michihiro Tsuchiya President, Executive President, Representative Director
Age: 65
Kenichi Yanagisawa Senior Managing Executive Officer, Chief Director of Sales, Director
Age: 63
Takashi Kobayashi Managing Executive Officer, Director
Age: 57
Kenkichi Kosakai Managing Executive Officer, Director
Age: 59
Yoshiaki Ishizaki Managing Executive Officer, Chief Director of Reliability Guarantee
Seiichi Murakami Managing Executive Officer
Minoru Muramatsu Managing Executive Officer
Koji Nakamura Managing Executive Officer, Chief Director of Medicine Manufacturing, President of Subsidiary
Tsutomu Anno Executive Officer, Deputy Chief Director of Sales, Director of Sales Promotion
Shigeki Nakata Executive Officer, Deputy Chief Director of Sales